205 related articles for article (PubMed ID: 15001956)
21. Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden.
Torre F; Basso M; Giannini EG; Feasi M; Boni S; Grasso A; De Leo P; Dodi F; Marazzi MG; Azzola E; Bartolacci V; Percario G; Beltrame A; Borro P; Picciotto A;
J Med Virol; 2009 Nov; 81(11):1882-6. PubMed ID: 19774694
[TBL] [Abstract][Full Text] [Related]
22. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion.
Ni YH; Chang MH; Chen PJ; Tsai KS; Hsu HY; Chen HL; Tsuei DJ; Chen DS
Gastroenterology; 2007 Jun; 132(7):2340-5. PubMed ID: 17570209
[TBL] [Abstract][Full Text] [Related]
23. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.
Yuen MF; Tanaka Y; Fong DY; Fung J; Wong DK; Yuen JC; But DY; Chan AO; Wong BC; Mizokami M; Lai CL
J Hepatol; 2009 Jan; 50(1):80-8. PubMed ID: 18977053
[TBL] [Abstract][Full Text] [Related]
24. HLA typing associated with hepatitis B E antigen seroconversion in children with chronic hepatitis B virus infection: a long-term prospective sibling cohort study in Taiwan.
Wu JF; Chen CH; Hsieh RP; Shih HH; Chen YH; Li CR; Chiang CY; Shau WY; Ni YH; Chen HL; Hsu HY; Chang MH
J Pediatr; 2006 May; 148(5):647-651. PubMed ID: 16737879
[TBL] [Abstract][Full Text] [Related]
25. Mutations of T-cell epitopes in the hepatitis B virus surface gene in children with chronic infection and hepatocellular carcinoma.
Ni YH; Chang MH; Hsu HY; Tung YC; Chen HL; Wang KJ; Tsuei DJ; Young NC
Am J Gastroenterol; 2008 Apr; 103(4):1004-9. PubMed ID: 18190649
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.
Truong BX; Seo Y; Kato M; Hamano K; Ninomiya T; Katayama M; Kato H; Yano Y; Hayashi Y; Kasuga M
Int J Mol Med; 2005 Aug; 16(2):279-84. PubMed ID: 16012762
[TBL] [Abstract][Full Text] [Related]
27. Viral hepatitis and hepatocellular carcinoma.
Marrero CR; Marrero JA
Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
[TBL] [Abstract][Full Text] [Related]
28. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
29. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.
Nguyen VT; Law MG; Dore GJ
J Viral Hepat; 2009 Jul; 16(7):453-63. PubMed ID: 19302335
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.
Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
J Gastroenterol; 2005 Feb; 40(2):148-56. PubMed ID: 15770398
[TBL] [Abstract][Full Text] [Related]
32. Development of hepatocellular carcinoma in chronic viral B and viral C liver diseases.
Acalovschi M
Rom J Gastroenterol; 2003 Jun; 12(2):123-30. PubMed ID: 12853999
[No Abstract] [Full Text] [Related]
33. Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment.
Sherman M
Cleve Clin J Med; 2009 May; 76 Suppl 3():S6-9. PubMed ID: 19465708
[TBL] [Abstract][Full Text] [Related]
34. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
35. Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.
Lin SM; Yu ML; Lee CM; Chien RN; Sheen IS; Chu CM; Liaw YF
J Hepatol; 2007 Jan; 46(1):45-52. PubMed ID: 17107734
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic strategies for chronic hepatitis B virus infection in 2008.
Khokhar A; Afdhal NH
Am J Med; 2008 Dec; 121(12 Suppl):S33-44. PubMed ID: 19185073
[TBL] [Abstract][Full Text] [Related]
37. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
[TBL] [Abstract][Full Text] [Related]
38. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F.
Livingston SE; Simonetti JP; Bulkow LR; Homan CE; Snowball MM; Cagle HH; Negus SE; McMahon BJ
Gastroenterology; 2007 Nov; 133(5):1452-7. PubMed ID: 17920063
[TBL] [Abstract][Full Text] [Related]
39. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
[TBL] [Abstract][Full Text] [Related]
40. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]